“RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS”. 2022. Journal of Pharmaceutical Negative Results, December, 5734-43. https://doi.org/10.47750/pnr.2022.13.S07.696.